Inventaire - 友達とコミュニティはあなたのベストな図書館です

Cost-effectiveness of SQ® HDM SLIT-tablet in addition to pharmacotherapy for the treatment of house dust mite allergic rhinitis in Germany.

著者

Julie Hahn-Pedersen

Jörg Kleine-Tebbe

1957 - 2023

Ludger Klimek

1964 -

この作品が含まれる作品: ClinicoEconomics and Outcomes Research

出版日: 2017-02-16

言語: 英語

main subject: ドイツ, 薬物治療, ヤケヒョウヒダニ, アレルギー性鼻炎

Cites articles 19

Date

タイトル

著者

2016-01-30

Cost-Effectiveness of Immunotherapy in the Treatment of Seasonal Allergic Rhinitis: Identifying Product-Specific Parameters of Relevance for Health Care Decision-Makers and Clinicians

Claus Bachert
2015-12-02

How you ask is what you get: Framing effects in willingness-to-pay for a QALY

Lars Schwettmann
2015-08-17

Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial

Vibeke Backer, Jörg Kleine-Tebbe
2014-06-13

Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapy
2014-01-01

Evaluation of house dust mite allergy in real life: patients' characteristics and satisfaction with treatment

Giovanni Passalacqua
2013-09-09

Patient related outcomes in a real life prospective follow up study: Allergen immunotherapy increase quality of life and reduce sick days

Karin Dam Petersen, Christian Kronborg
2013-05-16

Annual cost of hospitalization, inpatient rehabilitation, and sick leave for head and neck cancers in Germany
2013-03-14

Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report

Marek Jutel, Cezmi Akdis, A Wesley Burks, Harold S. Nelson, Linda Cox, Moises A Calderon
2012-01-29

SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial

Stephen R Durham
2010-02-16

Continuous versus on-demand pharmacotherapy of allergic rhinitis: evidence and practice
2010-10-12

Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study

Giovanni Passalacqua, Giorgio Walter Canonica
2008-02-01

The voice of the patients: allergic rhinitis is not a trivial disease

Susanna Palkonen
2007

The Hawthorne Effect: a randomised, controlled trial
2007-07-03

Cost-effectiveness of GRAZAX for prevention of grass pollen induced rhinoconjunctivitis in Southern Europe
2005-12-02

Severity and impairment of allergic rhinitis in patients consulting in primary care.

Jean Bousquet
2005-11-01

Health-economic analyses of subcutaneous specific immunotherapy for grass pollen and mite allergy

Karin Dam Petersen
2004-11-01

Prevalence and rate of diagnosis of allergic rhinitis in Europe
2003-01-01

Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study

Karin Berger
2001-07-01

Specific immunotherapy in rhinitis and asthma

Pascal Demoly

記事 - wd:Q37652877

Welcome to Inventaire

友達やコミュニティの図書館

もっと調べる